Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05303519 |
|---|---|
| Brief Title: | Safusidenib Phase 2 Study in IDH1 Mutant Glioma |
| First Submitted : | March 13, 2022 |
| First Submitted that Met QC Criteria : | March 21, 2022 |
| First Posted : | March 31, 2022 |
| Last Update Submitted that Met QC Criteria : | November 13, 2023 |
| Last Update Posted : | November 14, 2023 |